Burosumab-Twza Injection
8 interactions 7 cited referencesBurosumab-twza injection is used to treat X-linked hypophosphatemia (XLH; an inherited disease where the body doesn't maintain phosphorus and that leads to weak bones) in adults and children 6 months of age and older. It is also used to treat tumor-induced osteomalacia (a tumor that causes a loss of phosphorus in the b… Read the full Burosumab-Twza Injection drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Contraindicated
Burosumab-Twza Injection Calcifediol Rayaldee Increased risk of hyperphosphatemia Details Burosumab-Twza Injection Calcitriol Rocaltrol Increased risk of hyperphosphatemia Details Burosumab-Twza Injection Dihydrotachysterol Increased risk of hyperphosphatemia Details Burosumab-Twza Injection Doxercalciferol Hectoral® Increased risk of hyperphosphatemia Details Burosumab-Twza Injection Paricalcitol Zemplar Increased risk of hyperphosphatemia Details Burosumab-Twza Injection Potassium Phosphate K-Phos Increased risk of hyperphosphatemia Details Burosumab-Twza Injection Sodium Phosphate, Dibasic Increased risk of hyperphosphatemia Details Burosumab-Twza Injection Sodium Phosphate, Monobasic Increased risk of hyperphosphatemia DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist